What is Dilon Technologies?
Founded in 1997, Dilon Technologies, Inc. is a prominent player in the medical device industry, dedicated to the development, manufacturing, and marketing of cutting-edge products. Their specialization spans critical areas such as hemostasis, cancer detection and assessment, and airway management. The company's commitment to innovation positions it as a key contributor to advancements in medical technology, aiming to improve patient outcomes and healthcare efficiency.
How much funding has Dilon Technologies raised?
Dilon Technologies has raised a total of $19.6M across 7 funding rounds:
Debt
$660K
Debt
$1.9M
Debt
$4M
Private Equity
$1.9M
Debt
$350K
Private Equity
$9M
Private Equity
$1.9M
Debt (2008): $660K, investors not publicly disclosed
Debt (2011): $1.9M, investors not publicly disclosed
Debt (2012): $4M, investors not publicly disclosed
Private Equity (2017): $1.9M, investors not publicly disclosed
Debt (2020): $350K backed by PPP
Private Equity (2025): $9M with participation from JGB Management
Private Equity (2025): $1.9M, investors not publicly disclosed
Key Investors in Dilon Technologies
JGB Management
JGB Management Inc. is an alternative asset management firm established in 2005 by Brett Cohen, specializing in niche credit-oriented situations and providing strategic investment solutions.
What's next for Dilon Technologies?
The recent major strategic investment signals a new phase of growth for Dilon Technologies. This capital infusion, coupled with the company's established expertise in medical device innovation, suggests a strategic focus on scaling operations, expanding market reach, and potentially accelerating the development pipeline for its specialized products. The company is poised to leverage this financial backing to further solidify its position in the competitive healthcare landscape and pursue new opportunities for technological advancement and commercialization.
See full Dilon Technologies company page
